Plasma is a composite mixture of more than 700 proteins and other substances which are vital for the smooth functioning of the human body. Plasma is the liquid component of blood, constituting around 50% of the total blood volume. Plasma in itself is approximately 90% water, with the remaining 10% comprising of proteins, minerals, clotting factors, hormones, and immunoglobins. Plasma is the raw material for the extraction of various proteins which are used for their therapeutic values. Plasma proteins cannot be manufactured rather the same are obtained or collected from a large pool of donors. View Full Report At : http://www.researchmoz.us/global-blood-plasma-market-report-2013-edition-report.html With the swift progression in the field of biomedical/healthcare technology, companies operating in the healthcare/pharmaceutical/therapeutic industry are now surmounting in the respective realm. Also, on account of the escalating incidences of health related issues originating due to changing lifestyle and continuously changing surroundings, blood plasma industry’s growth is augmented. In order to address the unmet medical needs related to blood disorders, autoimmune diseases and liver function impairment among others, associated companies are coming up with novel and improved treatment options like IVIG, albumin, clotting factors etc. which are derived from human blood plasma.

1. Global Blood Plasma Market Report: 2013 Edition
Plasma is a composite mixture of more than 700 proteins and other substances which are vital for the smooth
functioning of the human body. Plasma is the liquid component of blood, constituting around 50% of the total
blood volume. Plasma in itself is approximately 90% water, with the remaining 10% comprising of proteins,
minerals, clotting factors, hormones, and immunoglobins. Plasma is the raw material for the extraction of
various proteins which are used for their therapeutic values. Plasma proteins cannot be manufactured rather
the same are obtained or collected from a large pool of donors.
With the swift progression in the field of biomedical/healthcare technology, companies operating in the
healthcare/pharmaceutical/therapeutic industry are now surmounting in the respective realm. Also, on account
of the escalating incidences of health related issues originating due to changing lifestyle and continuously
changing surroundings, blood plasma industry’s growth is augmented. In order to address the unmet
medical needs related to blood disorders, autoimmune diseases and liver function impairment among others,
associated companies are coming up with novel and improved treatment options like IVIG, albumin, clotting
factors etc. which are derived from human blood plasma.
The blood plasma industry is highly regulated to ensure the safety of collected plasma and protect donors.
The market is characterized by fast pace developments in the clinical technology and testing methodology.
This report elicits the global blood plasma market with focus on segmental markets like IVIG, albumin and
hemophilia market. Also the regions including the US and China are covered. Moreover, market dynamics like
the key trends, industry developments, growth drivers and challenges are analyzed in detail. Furthermore, the
competitive landscape of the industry is highlighted. The rivalry prevalent in the global blood plasma market
is quite fierce with numerous local and global players contenting for the market share. On the global front, the
key players are Baxter, CSL, Grifols and Octapharma.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we
have predicted the future growth of the industry. We employed various significant variables that have an
impact on this industry and created regression models with SPSS Base to determine the future direction of the
industry. Before deploying the regression model, the relationship between several independent or predictor
variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and
tests.
table Of Content
1. Overview
1.1 Components Of Blood Plasma
1.2 Functions Of Blood Plasma
1.3 Collection And Extraction Of Plasma
1.3.1 Plasma Collection
1.3.2 Plasma Extraction
1.3.3 Plasma Fractionation Yield
Global Blood Plasma Market Report: 2013 Edition

2. 1.3.4 Plasma Usage
2. Blood Plasma Market Structure
2.1 Global Blood Plasma Market
market Value
market Segments
2.1.1 Plasma Industry Cost Structure
2.1.2 Plasma Market Of The Us
2.2 Global Ivig Market
market Value
demand & Supply
breakdown By Region
2.2.1 Ivig Market Of The Us
2.3 Global Hemophilia Market
hemophilia A
hemophilia B
2.3.1 Fviii Market Of The Us
2.4 Albumin Market
2.4.1 Albumin Market Of China And The Us
3. Market Dynamics
3.1 Key Trends
3.1.1 Kinetics Of Plasma-collection Industry
3.1.2 Reimbursement
3.1.3 Growing Penetration Of Rfviii Products In Emerging Markets – Opportunity For Manufacturers
3.1.4 A1pi Deficiency- Confined To Prevention Only
3.2 Industry Developments
3.2.1 Improved Biological Molecule Formulations
3.2.2 Baxter’s Phase I Clinical Trial Of Treatment For Hemophilia A
Global Blood Plasma Market Report: 2013 Edition

3. 3.3 Growth Drivers
3.3.1 Increasing New Patient Registration For Hemophilia Treatment
3.3.2 Increased Usage Of Plasma Derived Products
3.3.3 Rising Healthcare Expenditure
3.3.4 Higher Spending On Medicines
3.3.5 Rising Demand For Better Healthcare Options
3.3.6 Launch Of Nmes (new Molecular Entities)
3.3.7 Growing Ageing Population (+60 Years)
3.3.8 Rising Male Population
3.3.9 Ameliorating Economic Conditions
3.4 Challenges
3.4.1 Increasing Regulation In The Plasma-collection Industry
3.4.2 Escalating Price Pressure
3.4.3 Constrained Plasma Fractionation Capacity
3.4.4 Misdiagnosis Of The Disease
4. Competitive Landscape
4.1 Blood Plasma Market Rivalry
4.2 Plasma Derivatives Market Contention
4.2.1 Immunoglobulins
ivig Market Of Europe
ivig Market Of North America
ivig Market Of The Us
4.2.2 Albumin Market
albumin Market Of The Us
albumin Market Of China
4.2.3 Other Products
5. Company Profiles
5.1 Baxter International Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Global Blood Plasma Market Report: 2013 Edition

4. focus On Investment In R&d
growth Through Sustainable Development
5.2 Grifols
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
expansion In Other Geographic Regions
growth Through Mergers And Acquisitions
5.3 Csl Limited
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
focus On R&d
expanding Product Portfolio
5.4 Octapharma
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
focus On Innovation
expansion Of Production Facilities
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent And Independent Variables
6.2.2 Correlation Analysis
Global Blood Plasma Market Report: 2013 Edition

5. 6.2.3 Regression Analysis
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Global Blood Plasma Market Report: 2013 Edition